GenMont Biotech (3164.TW) Stock Price

GenMont Biotech Price

CLOSED
16.85
​
Market closed

Over the last 19 years GenMont Biotech grew revenue by 4.6% annually, reaching 401.23 M TWD. Earnings per share have grown at 9.7% per year over the last 19 years. For GenMont Biotech, the net margin of 14.3% is down versus 26.4% a few years ago. At today's price the dividend yield works out to roughly 4.75%. The payout ratio is around 110% of earnings. The dividend has grown at 2.3% per year over the past 17 years.

GenMont Biotech stock price

Access this data via the Eulerpool API

GenMont Biotech business model & stock analysis

Genmont Biotech Inc. engages in the research development, manufacturing, and selling of probiotic supplements. The company is headquartered in Tainan, Tainan. The company went IPO on 2003-06-12. The firm's major products include lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus casei, lactobacillus plantarum, lactobacillus fermentum, lactobacillus salivarius, lactobacillus acidophilus, lactobacillus reuteri, lactobacillus brevis, lactobacillus bulgaricus, lactobacillus gasseri, lactobacillus johnsonii and others. The Company’s products are applied to enhance human immunity against dust allergy and digestive system health care. The firm distributes its products in domestic market and to overseas markets.

Frequently asked questions about GenMont Biotech

Converted at the current exchange rate, the GenMont Biotech share trades at 0.47 EUR (16.85 TWD).

The revenue cannot currently be calculated for GenMont Biotech.

The profit cannot currently be calculated for GenMont Biotech.

The P/E ratio cannot be calculated for GenMont Biotech at the moment.

The P/S cannot be calculated for GenMont Biotech currently.

The Eulerpool Quality Score for GenMont Biotech is 2/10.

The ISIN of GenMont Biotech is TW0003164000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of GenMont Biotech is 3164.TW. The ticker symbol is used to trade GenMont Biotech shares on the stock exchange.

Fair ValueTerminal
15.84 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Jun 12, 2003
ISIN
TW0003164000
Cusip
Y2692X109
Market capitalization
1.45 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
25.21
P/B Ratio
1.09
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.97 %
Dividend
Dividend yield
4.75 %
Payout Ratio
109.53 %
Dividend growth Ø5Y
0.01 %
Dividend payments per year
1
Dividend paid since
3 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
21.00 %
Last updated Oct 13, 2026, 10:10 PM

GenMont Biotech Peer Group

GenMont Biotech FIGI

3164:TT (Taiwan Stock Exchange) · BBG000D1J038

All fundamentals and in-depth analysis of GenMont Biotech

Our stock analysis for GenMont Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GenMont Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.